RHYTHM PHARMACEUTICALS, INC. (RYTM)
Pharmaceutical Preparations
Latest Price
$96.77
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.51
P/B Ratio
64.17
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.67M | $740.0M | 9.69% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.16M | $683.0M | 8.95% | -80.2K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 5.60M | $622.0M | 8.14% | -- | 2026-06-30 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.17M | $351.0M | 4.60% | -248.7K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.14M | $348.0M | 4.56% | +96.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.01M | $333.0M | 4.37% | +38.2K | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.65M | $292.0M | 3.85% | +1.23M | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 2.59M | $287.0M | 3.76% | +212.5K | 2026-06-30 |
| STATE STREET CORP | 2.57M | $285.0M | 3.74% | +301.7K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.57M | $284.0M | 3.73% | +911.3K | 2026-06-30 |